🇺🇸 FDA
Company

Milestone

Milestone Pharmaceuticals

MIST pharma USA

Quick answer

Milestone is a pharma company (MIST) headquartered in MONTREAL, A8, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Etripamil

Paroxysmal Supraventricular Tachycardia

Phase 3 · small_molecule · terminated

1 trials project

Etripamil NS

Paroxysmal Supraventricular Tachycardia

Phase 3 · small_molecule · active

2 trials project

Etripamil NS 70 mg

Paroxysmal Supraventricular Tachycardia

Phase 3 · small_molecule · completed

2 trials project

Etripamil NS 70 mg

Tachycardia, Supraventricular

Phase 3 · small_molecule · completed

1 trials project

Placebo

Atrial Fibrillation

Phase 3 · small_molecule · active

1 trials project

Etripamil

Paroxysmal Supraventricular Tachycardia (PSVT)

Phase 2 · small_molecule · completed

1 trials project

Etripamil

Atrial Fibrillation

Phase 2 · small_molecule · completed

1 trials project

Etripamil Nasal Spray 70mg

Healthy Chinese Subjects

Phase 1 · small_molecule · completed

1 trials

Drugs (5)

drug

etripamil

CARDAMYST

 drug

mannitol

MANNITOL 25%

 drug

procaine hydrochloride

PROCAINE HYDROCHLORIDE

 drug

sodium chloride

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

 drug

sterile water for irrigation

STERILE WATER IN PLASTIC CONTAINER

Patents (8)

patent

US 12257224

Methods of administration for highly water-soluble salts of a short acting pheny

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10632255

Drug infusion device

Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10308609

Bicyclic compounds

Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10251851

Bicyclic analgesic compounds

Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10117848

Highly water-soluble salts of a short acting phenylalkylamine calcium channel bl

Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10010522

Short acting phenylalkylamine calcium channel blockers and uses thereof

Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10010524

Short acting phenylalkylamine calcium channel blockers and uses thereof

Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10010523

Short acting phenylalkylamine calcium channel blockers and uses thereof

Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)